Compare ATRC & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | PRGO |
|---|---|---|
| Founded | 2000 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2005 | 2013 |
| Metric | ATRC | PRGO |
|---|---|---|
| Price | $28.80 | $11.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $51.17 | $19.33 |
| AVG Volume (30 Days) | 706.1K | ★ 2.3M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.28% |
| EPS Growth | ★ 74.74 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $201,630,000.00 | $800,000.00 |
| Revenue This Year | $15.27 | N/A |
| Revenue Next Year | $12.21 | $1.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $26.62 | $9.23 |
| 52 Week High | $43.18 | $28.44 |
| Indicator | ATRC | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 49.91 | 51.19 |
| Support Level | $28.03 | $10.40 |
| Resistance Level | $30.75 | $12.13 |
| Average True Range (ATR) | 1.36 | 0.41 |
| MACD | 0.12 | 0.02 |
| Stochastic Oscillator | 54.98 | 21.26 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.